BOSTON SCIENTIFIC CORP (BSX) — research page

US · us-cm-kg/NYSE/BSX · as of 2026-11-08

Identity and listing

The issuer is BOSTON SCIENTIFIC CORP, listed on NYSE under ticker BSX, with ISIN US1011371077 and LEI Y6ZDD9FP4P8JSSJMW954. Its security type is Corporate and its sector is 3841 Surgical & Medical Instruments & Apparatus. Its jurisdiction is United States, Delaware. Its segment is not on the record. Its status is listed, not halted.

The disclosure read

The record holds 108 filings in the twelve months to 2026-11-08, across 55 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type directors_dealings. The NYSE median cadence gap is 6.0 days and the NYSE median latency is 4.0 days, across 3256 issuers. The sector median cadence gap is 6 days and the sector median latency is 4 days, across 129 issuers. The NYSE median filings count is 64.0 and the sector median filings count is 64.

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Ernst & Young LLP, located in Boston, Massachusetts. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's own investor-relations page names 28 research houses: AllianceBernstein, Baird, Barclays, BTIG LLC, Canaccord Genuity, Citi, Cleveland Research, Cowen, Deutsche Bank, Evercore ISI, Goldman Sachs, J.P. Morgan, Jefferies, Leerink Partners, Mizuho, Morgan Stanley, Needham & Co., Nephron Research LLC., Oppenheimer & Co., Piper Sandler, Raymond James, RBC, Redburn, Stifel, Truist, UBS, Wells Fargo Securities and Wolfe Research.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)

10.2

https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)

10.3

https://data.sec.gov/submissions/CIK0000885725.json (identity.jurisdiction)

10.4

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.5

https://mcp.us-cm-kg.ai/events/NYSE/BSX (the disclosure lines)

10.6

https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)

10.7

https://www.sec.gov/Archives/edgar/data/885725/000088572526000010/bsx-20251231.htm (the auditor)

10.8

https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)

10.9

https://investors.bostonscientific.com/stock/sell-side-analyst-coverage (coverage)

10.10

https://mcp.us-cm-kg.ai/record/NYSE/BSX (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US1011371077"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:c02627cab4bd4928.